Showing 4111-4120 of 7016 results for "".
- LNG IUS Outperformed Hysteroscopic Niche Resection At 3 Yearshttps://reachmd.com/news/lng-ius-outperformed-hysteroscopic-niche-resection-at-3-years/2487221/Key Takeaways Women assigned the levonorgestrel intrauterine system were more likely to meet the primary spotting reduction endpoint at 36 months. Improvement with the device continued through 36 months, while the hysteroscopic group improved through 2
- Four-Year RHONE-X Data Show Durable Faricimab Outcomes in DMEhttps://reachmd.com/news/four-year-rhone-x-data-show-durable-faricimab-outcomes-in-dme/2487161/Key Takeaways Visual acuity gains of about 10 to 11 letters were maintained, alongside sustained CST reductions and DME absence by study definition (CST < 325 μm) in more than 90% of patients at study end. About 80% of patients reached intervals of
- LaserAway Marks 20 Years with Continued National Expansionhttps://reachmd.com/news/laseraway-marks-20-years-with-continued-national-expansion/2487069/LaserAway is celebrating its 20th anniversary alongside continued national expansion and recent recognition within the aesthetics industry. The company, which specializes in aesthetic dermatology services, announced that it now operates more than 215 clinics across the United States. The c
- Pembrolizumab Plus Chemotherapy in KEYNOTE-590 at 5 Yearshttps://reachmd.com/news/pembrolizumab-plus-chemotherapy-in-keynote-590-at-5-years/2486906/Key Takeaways Long-term overall survival remained higher with pembrolizumab plus chemotherapy during extended follow-up. Progression-free survival findings also favored the pembrolizumab-containing regimen over time. Grade 3 or higher treatmen
- Nontargeted Hepatitis C Screening Yields More ED Diagnoseshttps://reachmd.com/news/nontargeted-hepatitis-c-screening-yields-more-ed-diagnoses/2486832/Key Takeaways Nontargeted screening was associated with more newly identified hepatitis C infections in this emergency department comparison. Targeted screening produced a higher proportion of new diagnoses among tested patients than nontargeted screen
- PRP Versus Corticosteroid In Lateral Elbow Tendinopathy: 1-Year Trial Resultshttps://reachmd.com/news/prp-versus-corticosteroid-in-lateral-elbow-tendinopathy-1-year-trial-results/2486565/A randomized controlled trial in adults with chronic lateral elbow tendinopathy compared a single ultrasound-guided leukocyte-rich platelet-rich plasma (PRP) injection with a c
- Yellow Fever in Pregnancy: Reassessing Risks, Outcomes, and Vaccination in the 2024–2026 Americas Outbreakhttps://reachmd.com/news/yellow-fever-in-pregnancy-reassessing-risks-outcomes-and-vaccination-in-the-20242026-americas-outbreak/2486475/
- GLP‑1 Use and Body Contouring: Reporting from a 10‑Year Panniculectomy Studyhttps://reachmd.com/news/glp1-use-and-body-contouring-reporting-from-a-10year-panniculectomy-study/2486407/A retrospective cohort analysis in body-contouring surgery reported outcome-specific associations between preoperative gluc
- Bimekizumab Shows Durable Psoriasis Clearance and 3-Year HS Controlhttps://reachmd.com/news/bimekizumab-shows-durable-psoriasis-clearance-and-3-year-hs-control/2486394/New analyses from the BE RADIANT and BE VIVID trials showed the durability of response with bimekizumab (Bimzelx; UCB) in treating plaque psoriasis, alongside positive long-term findings in hidradenitis suppurativa (HS). Resu
- No Link Between COVID-19 Vaccination and Sudden Cardiac Death in Youthhttps://reachmd.com/news/no-link-between-covid-19-vaccination-and-sudden-cardiac-death-in-youth-study-summary/2486363/A population-based analysis from Ontario examined whether prior COVID-19 vaccination was associated with sudden out-of-hospital death or death shortly after